汤剂
中医药
医学
芍药苷
心力衰竭
药效学
传统医学
药方
药理学
内科学
药代动力学
化学
替代医学
色谱法
病理
高效液相色谱法
作者
Lili Hong,Chenyu Yang,Yan Zhao,Hong‐Song Wang,Weidong Chen,Xiaoyu Cheng
出处
期刊:PubMed
[National Institutes of Health]
日期:2021-11-01
卷期号:46 (21): 5512-5521
被引量:3
标识
DOI:10.19540/j.cnki.cjcmm.20210705.203
摘要
Zhenwu Decoction(ZWD) has a history of more than 1 800 years in traditional Chinese medicine(TCM), which is used to treat various diseases characterized by Yangqi deficiency and exuberant water and dampness. It is currently the classic prescription for the treatment of chronic heart failure(CHF). This study provides a basis for the treatment of CHF with ZWD by elaborating the traditional efficacy, theoretical basis, and underlying mechanism of the prescription. Based on the research methods and judgment basis of quality markers(Q-markers) of Chinese medicine, the Q-markers of ZWD in the treatment of CHF were predicted from the aspects of transfer and traceability, specificity, effectiveness, compatibility environment, measurability, and processing. Demethyl-coclaurine,benzoylaconine, atractylenolide Ⅲ, paeoniflorin, 6-gingerol, 8-gingerol, pachymic acid, and dehydrotumulosic acid can be used as Q-markers of ZWD for treating CHF. The result provides a reference for exploring the pharmacodynamic substances of ZWD in the treatment of CHF.
科研通智能强力驱动
Strongly Powered by AbleSci AI